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  Lichen	   sclerosus	   (LS)	   is	   a	   chronic,	   autoimmune,	   inﬂammatory	   skin	  
disease	  of	  uncertain	  aeDology	  	  
  Vulvar	   lichen	   sclerosus	   is	   associated	   with	   severe	   discomfort	   and	  
morbidity	  	  
  When	   unresponsive	   to	   medical	   therapies,	   photodynamic	   therapy	  
(PDT)	  has	  been	  described	  as	  a	  potenDal	  alternaDve	  treatment	  with	  
symptomaDc	  beneﬁt	  	  
  However,	  pain	   is	  sDll	  a	  major	   limitaDon	  to	  this	  technique,	  and	  
an	  important	  cause	  of	  treatment	  disconDnuaDon	  	  
  Pain	  control	  strategies	  during	  PDT	  have	  been	  studied,	  but	  none	  
has	  been	  determined	  as	  completely	  eﬀecDve	  	  
  ♀,	  75	  years-­‐old	  
  Vulvar	  lichen	  sclerosus	  
–  15	  years	  of	  evoluDon	  
–  Highly	  symptomaDc	  
–  Persistent	   pain,	   burning,	  
pruritus,	   and	   severe	  
dysuria	  
  Irresponsive	   to	   treatment	  
with	   clobetasol	   propionate	  
0.05%	  ointment	  +	  amitriptylin	  
10	  mg/day	  for	  12	  months	  
PHOTODYNAMIC	  THERAPY	  
with	  methyl	  aminolevulinate	  	  
Figure	  1.	  A	  shiny,	  ivory,	  smooth-­‐surfaced	  
plaque	   surrounding	   the	   vulva,	   with	  
important	   atrophy	   causing	   labial	   and	  
clitoris	  resorpDon,	  and	  narrowing	  of	  the	  
introitus.	  	  
Figure	  2.	  Hystopathological	  examinaDon	  
conﬁrming	   the	   clinical	   diagnosis	   of	  
lichen	   sclerosus:	   a	   band	   lymphocyDc	  
inﬁltrate	   is	   observed	   in	   the	   superﬁcial	  




Perineum	  illuminaDon	  during	  
photodynamic	  therapy	  =	  INTENSE	  PAIN	  
Inhaled	  50%	  nitrous	  oxide/oxygen	  
premix	  	  
Conscious	  seda7on	  +	  analgesia	  
Painless	  treatment,	  no	  side-­‐eﬀects:	  
  PDT:	  red	  light,	  630	  nm	  
  37	  J/cm2,	  8’	  20’’	  
  Distance	  of	  8	  cm	  between	  the	  device	  
and	  skin	  surface	  
A	  visual	  analogue	  scale	  was	  used	  to	  
evaluate	  response	  to	  PDT	  
3	  
4	  
Graphic	  1.	  A	  total	  of	  4	  PDT	  sessions	  were	  performed.	  SymptomaDc	  relief	  was	  reported	  as	  soon	  
as	   one	   week	   afer	   the	   ﬁrst	   treatment.	   Dysuria	   remiged	   afer	   the	   ﬁrst	   session.	   Pain	   and	  
pruritus	   reduced	   up	   to	   80%	   from	   baseline	   afer	   each	   treatment.	   Overall,	   while	   clinically	  
unchanged,	   symptomaDc	   response	   has	   been	   observed	   with	   every	   treatment,	   with	   longer	  




























10	  wks	   9	  wks	   40	  wks	  
  When	  inhaled,	  a	  ready	  to	  use	  medical	  gas	  mixture	  consisDng	  of	  50%	  nitrous	  oxide	  and	  
50%	  oxygen	  produces	  a	  pain-­‐relieving,	  anxiolyDc,	  and	  sedaDve	  eﬀect	  without	   loss	  of	  
consciousness;	  it	  is:	  	  
  fast-­‐acDng,	  self-­‐regulated,	  and	  rapidly	  eliminated	  once	  inhalaDon	  stops	  
  safe	  (minimal,	  reversible	  side	  eﬀects	  include	  drowsiness,	  euphoria	  and	  nausea)	  	  
  used	  in	  short-­‐term	  procedures	  in	  which	  analgesia	  and	  sedaDon	  with	  rapid	  onset	  
and	  oﬀset	  is	  sought	  	  
  easily	  managed	  in	  outpaDent	  clinics	  by	  trained	  dermatologists	  
  In	  the	  described	  case,	  the	  extension	  and	  the	  localizaDon	  of	  LS	  would	  hardly	  enable	  a	  
non-­‐traumaDc	  perineum	   illuminaDon;	  pain	   control	   facilitated	  paDent’s	  adherence	   to	  
treatment	  and	  acceptance	  of	  subsequent	  sessions.	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  PDT	  appears	  to	  be	  eﬀecDve	  in	  the	  symptomaDc	  treatment	  of	  vulvar	  LS	  
  To	   the	  authors’	   knowledge	   this	   is	   the	  ﬁrst	   case	   reporDng	   the	  use	  of	   inhaled	  nitrous	  
oxide/oxygen	  gas	  mixture	  during	  PDT	  performed	  in	  the	  genital	  area.	  Its	  analgesic	  and	  
sedaDve	  eﬀects	  may	  increase	  paDents’	  adherence	  to	  this	  painful	  procedure.	  	  
